JESSICA SHERBIN: Open Payments
NPI 1821760448 · FARMINGTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 48 payments from 12 companies in 2025. Trend: 2023 $732 · 2024 $800 · 2025 $1,108
Food & beverage: $1,108
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $618 |
| AstraZeneca Pharmaceuticals LP | 9 | $158 |
| Lilly USA, LLC | 4 | $58 |
| PFIZER INC. | 2 | $56 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42 |
| Exact Sciences Corporation | 1 | $26 |
| ABBVIE INC. | 1 | $25 |
| Boston Scientific Corporation | 1 | $22 |
| ALK-Abello, Inc | 1 | $17 |
Products named: Ozempic, AIRSUPRA, Rybelsus, MOUNJARO, PAXLOVID, OFEV, TRELEGY ELLIPTA, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
